Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use

Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use

Abstract Background Patients diagnosed as diffuse large B cell lymphoma (DLBCL) with CD5 positive normally have a worse outcome and poorly respond to the regulatory treatment strategy. Results We recently reported differently expressed tRFs and their potential target-genes of tRFs in patients with C...

Full description

Bibliographic Details
Main Authors: Qingyuan Qu, Ying Li, Xiaosheng Fang, Lingyan Zhang, Chao Xue, Xueling Ge, Xin Wang, Yujie Jiang
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Biology Direct
Subjects:
tRFs
DLBCL
Bioinformatics
Hub gene
Online Access:http://link.springer.com/article/10.1186/s13062-019-0255-8

Internet

http://link.springer.com/article/10.1186/s13062-019-0255-8

Similar Items